Marico
- Market cap
- ₹ 99,347 Cr.
- P/E
- 52.6x
- P/B
- 23.85x
- 52-week range
- 705.8 – 889.1
- ROE
- 43%
- ROCE
- 47%
- Dividend yield
- 0.5%
- Debt / equity
- 0.23
- Sector
- Agricultural Food & other Products
- Industry
- Edible Oil
- Listed on
- NSE, BSE
About
Marico Limited is an India-based consumer goods company operating in the global beauty and wellness categories. The Company operates in product categories such as Coconut Oil, Refined Edible Oils, Value Added Hair Oils, Leave-in Hair Conditioners, Male Grooming and Packaged Foods, among others. Its product portfolio caters to a diverse range of consumer needs and preferences, ranging from hair nourishment and styling to nutrition, immunity, and healthy snacking. The Company manufactures and markets products under the brands such as Parachute, Saffola, Saffola FITTIFY, Hair & Care, Parachute Advansed, Nihar Naturals, Mediker, Pure Sense, Coco Soul, Revive, Set Wet, Livon, Beardo, Just Herbs, True Elements and Plix. The Company's international product portfolio includes brands, such as Parachute, Parachute Advansed, HairCode, Fiancee, Purite de Provence, oliv, Caivil, Hercules, Black Chic, Code 10, Ingwe, X-Men, Thuan Phat and IsoPlus.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Edible Oil: 38 companies →Marico against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)52.6 against a typical 19.1: pricier than most peers (1st = cheapest).32nd of 37
- Sales growth+22.9% against a typical +8.9% from a year earlier.7th of 29
- Profit growth+27.1% against a typical +52.5% from a year earlier.17th of 26
- Share price, 3 months−11.7% against a typical −7.1%.24th of 32
- Size₹ 99,347.4 Cr. market value against a typical ₹ 130.2 Cr. (1st = largest).1st of 31
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CRISIL | — | Stable | 2 Sep 2026 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 2 Sep 2026 | Reaffirmed | — | — | CRISIL | ₹ 1,087 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 2 Nov 2026Upcoming | Financial Results | Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, November 2, 2026, to inter-alia, consider and approve the un-audited standalone & consolidated financial results of the Company for the quarter and half year ended September 30, 2026, along with the Limited Review Report of the Auditors thereon. |
| 4 Aug 2026 | Financial Results | Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, August 4, 2026, to inter alia, consider and approve the un-audited standalone & consolidated financial results of the Company for the quarter ended June 30, 2026, along with the Limited Review Report of the Auditors thereon. |
| 5 May 2026 | Financial Results/Dividend | Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, May 5, 2026, to inter-alia:i. consider and approve the Audited Standalone & Consolidated financial results of the Company for the quarter and financial year ended March 31, 2026; ii. take on record the Auditor s Report on Standalone & Consolidated financial results; andiii. consider a proposal for recommendation of Final Equity Dividend, if any, for the Financial Year 2025-26, for approval of the shareholders at the ensuing 38th Annual General Meeting of the Company. |
| 27 Jan 2026 | Financial Results | Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, January 27, 2026, to inter-alia, consider and approve the un-audited standalone & consolidated financial results of the Company for the quarter ended December 31, 2025, along with the Limited Review Report of the Auditors thereon. |
| 14 Nov 2025 | Financial Results | Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, November 14, 2025, to inter-alia, consider and approve the un-audited standalone & consolidated financial results of the Company for the quarter and half year ended September 30, 2025, along with the Limited Review Report of the Auditors thereon. |
| 4 Aug 2025 | Financial Results | Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, August 4, 2025, to inter alia, consider and approve the un-audited standalone & consolidated financial results of the Company for the quarter ended June 30, 2025, along with the Limited Review Report of the Auditors thereon. |
| 2 May 2025 | Financial Results | Pursuant to Regulation 29 of the SEBI (Listing Obligation and Disclosure Requirements) Regulation, 2015, we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, May 2, 2025, to inter-alia: i. consider and approve the Audited standalone & consolidated financial results of the Company for the quarter and financial year ended March 31, 2025; and ii. take on record the Auditor's Report on the standalone & consolidated financial results. |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,476 | 2,422 | 2,278 | 2,643 | 2,664 | 2,794 | 2,730 | 3,221 | 3,482 | 3,537 | 3,301 | 3,957 |
| Expenses | 1,979 | 1,909 | 1,836 | 2,017 | 2,142 | 2,261 | 2,272 | 2,566 | 2,922 | 2,945 | 2,780 | 3,138 |
| Operating Profit | 497 | 513 | 442 | 626 | 522 | 533 | 458 | 655 | 560 | 592 | 521 | 819 |
| OPM % | 20% | 21% | 19% | 24% | 20% | 19% | 17% | 20% | 16% | 17% | 16% | 21% |
| Other Income | 38 | 43 | 15 | 37 | 82 | 42 | 47 | 56 | 49 | 39 | 60 | 48 |
| Interest | 20 | 19 | 17 | 17 | 11 | 13 | 12 | 10 | 12 | 14 | 17 | 21 |
| Depreciation | 39 | 42 | 41 | 41 | 41 | 44 | 52 | 45 | 47 | 50 | 60 | 56 |
| Profit before tax | 476 | 495 | 399 | 605 | 552 | 518 | 441 | 656 | 550 | 567 | 504 | 790 |
| Tax % | 24% | 22% | 20% | 22% | 22% | 22% | 22% | 22% | 21% | 19% | 19% | 17% |
| Net Profit | 360 | 386 | 320 | 474 | 433 | 406 | 345 | 513 | 432 | 460 | 408 | 652 |
| EPS in Rs | 2.73 | 2.96 | 2.46 | 3.58 | 3.27 | 3.08 | 2.65 | 3.89 | 3.24 | 3.44 | 3.01 | 4.85 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 9%
- 5 Years
- 11%
- 3 Years
- 12%
- TTM
- 25%
- 10 Years
- 10%
- 5 Years
- 9%
- 3 Years
- 11%
- TTM
- 13%
- 10 Years
- 11%
- 5 Years
- 10%
- 3 Years
- 15%
- TTM
- —
- 10 Years
- 38%
- 5 Years
- 39%
- 3 Years
- 41%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Marico | ₹ 769.65 | ₹ 99,347 Cr. | 52.6x | 23.9x | 43% | — |
| Hindustan Unilever | ₹ 1,820.00 | ₹ 4,27,626 Cr. | 48.3x | 10.3x | 21.5% | 16.1% |
| Godrej Consumer Products | ₹ 851.50 | ₹ 87,134 Cr. | 54.2x | 8.7x | 15.1% | 12.3% |
| Dabur India | ₹ 366.00 | ₹ 64,927 Cr. | 40x | 6.6x | 17.1% | 14.2% |
| Cupid | ₹ 306.50 | ₹ 41,214 Cr. | 271.9x | 64.1x | 27.3% | 30.3% |
| Gillette India | ₹ 7,222.60 | ₹ 23,535 Cr. | 38.9x | 26.9x | 66.4% | 21.1% |
Management
- Saugata Gupta
- Chief Executive Officer, Managing Director, Executive Director
- Pawan Agrawal
- Group Chief Financial Officer, Chief Executive Officer - International Business
- Ashish Goupal
- Chief Executive Officer India Core Business
- Amit Prakash
- Chief Human Resources Officer
- Vrijesh Nagathan
- Chief Information and Digital Technology Officer
- Vinay M. A.
- Compliance Officer, Company Secretary
- Amit Bhasin
- Chief Legal Officer
- Shilpa Vohra
- Chief Research and Development Officer
Prices are delayed and for information only. Nothing on this page is investment advice.